Integration of Neurocognitive Biomarkers Into a Neuro-Oncology Clinic

Baptist Health South Florida logo

Baptist Health South Florida

Status

Enrolling

Conditions

Neurocognitive Disorders

Treatments

Other: Observational study

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT05504681
2020-KOT-004

Details and patient eligibility

About

This is prospective observational registry study that will assess 1) if the neurocognitive function app (Brainlab Cognition) can be used in a widespread neuro-oncology clinic setting and 2) if patient reported quality of life parameters can be obtained electronically and integrated into clinic.

Enrollment

200 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

1. All adult (18+) patients with central nervous system (CNS) tumors, both primary brain malignancies and brain metastases, treated with radiotherapy (partial brain, stereotactic radiosurgery, stereotactic fractionated radiotherapy, or whole-brain radiotherapy), surgery, and/or antineoplastic therapy and followed thereafter at Miami Cancer Institute (MCI) 2. Life expectancy ≥ 6 months 3. Willingness to participate in ongoing registration study

Exclusion criteria

1. Patients receiving radiotherapy to the brain for functional disease (arteriovenous malformations, trigeminal neuralgia, essential tremors, etc.) 2. Pediatric patients (\<18 years old), pregnant women, and prisoners.

Trial contacts and locations

1

Loading...

Central trial contact

Rupesh R Kotecha; Jessica Injiac

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems